-
Something wrong with this record ?
The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study
M. Fajfr, M. Louda, P. Paterová, L. Ryšková, J. Pacovský, J. Košina, H. Žemličková, M. Broďák,
Language English Country Great Britain
Document type Journal Article
NLK
BioMedCentral
from 2001-12-01
BioMedCentral Open Access
from 2001
Directory of Open Access Journals
from 2001
Free Medical Journals
from 2001
PubMed Central
from 2001
Europe PubMed Central
from 2001
ProQuest Central
from 2009-01-01
Open Access Digital Library
from 2001-08-01
Open Access Digital Library
from 2001-01-01
Open Access Digital Library
from 2001-01-01
Medline Complete (EBSCOhost)
from 2001-01-01
Health & Medicine (ProQuest)
from 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
Springer Nature OA/Free Journals
from 2001-12-01
- MeSH
- Anti-Bacterial Agents pharmacology MeSH
- beta-Lactamases MeSH
- Fosfomycin pharmacology MeSH
- Gram-Negative Bacteria drug effects isolation & purification MeSH
- Urinary Tract Infections microbiology MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic MeSH
BACKGROUND: Against a background of rapid increase of β-lactamase-producing or multi-resistant pathogenic bacteria and the resulting lack of effective antibiotic treatment, some older antibiotics have been tested for new therapeutic uses. One of these is fosfomycin, to which according to studies these resistant bacteria are very sensitive. Our study was designed because there is no data on the fosfomycin susceptibility rate in the Czech Republic. METHOD: In this study from January 2013 to June 2014 3295 unique isolates of Gram-negative bacteria which had caused urinary tract infections were examined. The antibiotic susceptibility was measured by disk diffusion test. Both EUCAST and CLSI guidelines criteria (for fosfomycin only) were used for the antibiotic susceptibility evaluation. RESULTS: The most frequently tested bacterial isolates were Escherichia coli (51.3%, n = 1703), Klebsiella pneumoniae (19.4%, n = 643) and Proteus spp. (11.8%, n = 392). Among all isolates 29.0% (n = 963) were resistant to fluoroquinolones, 11.3% (n = 374) produced extended spectrum β-lactamase and 4.2% (n = 141) produced AmpC β-lactamase. The overall in vitro susceptibility was significantly higher for fosfomycin compared to the other tested per-oral antibiotics (nitrofurantoin, ampicillin, co-trimoxazole, ciprofloxacin and cefuroxime) against all tested Gram-negative rod isolates (excluding Morganella morgani and Acinetobacter spp. isolates). Fosfomycin also remained highly active against those isolates with extended spectrum β-lactamase (ESBL) production (95.8% in Escherichia coli isolates and 85.3% in Klebsiella pneumoniae isolates), unlike other tested per-oral antibiotics, which showed significant (p < 0.0001) susceptibility decrease. CONCLUSION: We have confirmed in the Czech Republic the very high susceptibility to fosfomycin trometamol of urinary tract infection pathogens, particularly Gram-negative rods including those producing β-lactamase.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18010638
- 003
- CZ-PrNML
- 005
- 20180418095931.0
- 007
- ta
- 008
- 180404s2017 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s12894-017-0222-6 $2 doi
- 035 __
- $a (PubMed)28446177
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Fajfr, Miroslav $u Institute of Clinical Microbiology, University Hospital Hradec Kralové, Sokolska 581, Hradec Králové, 50005, Czech Republic. miroslav.fajfr@fnhk.cz. Charles University in Prague, Faculty of Medicine in Hradec Kralové, Simkova 870, Hradec Kralove, 500 38, Czech Republic. miroslav.fajfr@fnhk.cz.
- 245 14
- $a The susceptibility to fosfomycin of Gram-negative bacteria isolates from urinary tract infection in the Czech Republic: data from a unicentric study / $c M. Fajfr, M. Louda, P. Paterová, L. Ryšková, J. Pacovský, J. Košina, H. Žemličková, M. Broďák,
- 520 9_
- $a BACKGROUND: Against a background of rapid increase of β-lactamase-producing or multi-resistant pathogenic bacteria and the resulting lack of effective antibiotic treatment, some older antibiotics have been tested for new therapeutic uses. One of these is fosfomycin, to which according to studies these resistant bacteria are very sensitive. Our study was designed because there is no data on the fosfomycin susceptibility rate in the Czech Republic. METHOD: In this study from January 2013 to June 2014 3295 unique isolates of Gram-negative bacteria which had caused urinary tract infections were examined. The antibiotic susceptibility was measured by disk diffusion test. Both EUCAST and CLSI guidelines criteria (for fosfomycin only) were used for the antibiotic susceptibility evaluation. RESULTS: The most frequently tested bacterial isolates were Escherichia coli (51.3%, n = 1703), Klebsiella pneumoniae (19.4%, n = 643) and Proteus spp. (11.8%, n = 392). Among all isolates 29.0% (n = 963) were resistant to fluoroquinolones, 11.3% (n = 374) produced extended spectrum β-lactamase and 4.2% (n = 141) produced AmpC β-lactamase. The overall in vitro susceptibility was significantly higher for fosfomycin compared to the other tested per-oral antibiotics (nitrofurantoin, ampicillin, co-trimoxazole, ciprofloxacin and cefuroxime) against all tested Gram-negative rod isolates (excluding Morganella morgani and Acinetobacter spp. isolates). Fosfomycin also remained highly active against those isolates with extended spectrum β-lactamase (ESBL) production (95.8% in Escherichia coli isolates and 85.3% in Klebsiella pneumoniae isolates), unlike other tested per-oral antibiotics, which showed significant (p < 0.0001) susceptibility decrease. CONCLUSION: We have confirmed in the Czech Republic the very high susceptibility to fosfomycin trometamol of urinary tract infection pathogens, particularly Gram-negative rods including those producing β-lactamase.
- 650 _2
- $a antibakteriální látky $x farmakologie $7 D000900
- 650 _2
- $a Česká republika $7 D018153
- 650 _2
- $a fosfomycin $x farmakologie $7 D005578
- 650 _2
- $a gramnegativní bakterie $x účinky léků $x izolace a purifikace $7 D006090
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a infekce močového ústrojí $x mikrobiologie $7 D014552
- 650 _2
- $a beta-laktamasy $7 D001618
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Louda, Miroslav $u Charles University in Prague, Faculty of Medicine in Hradec Kralové, Simkova 870, Hradec Kralove, 500 38, Czech Republic. Clinic of Urology, University Hospital Hradec Kralové, Sokolska 581, Hradec Králové, 50005, Czech Republic.
- 700 1_
- $a Paterová, Pavla $u Institute of Clinical Microbiology, University Hospital Hradec Kralové, Sokolska 581, Hradec Králové, 50005, Czech Republic. Charles University in Prague, Faculty of Medicine in Hradec Kralové, Simkova 870, Hradec Kralove, 500 38, Czech Republic.
- 700 1_
- $a Ryšková, Lenka $u Institute of Clinical Microbiology, University Hospital Hradec Kralové, Sokolska 581, Hradec Králové, 50005, Czech Republic. Charles University in Prague, Faculty of Medicine in Hradec Kralové, Simkova 870, Hradec Kralove, 500 38, Czech Republic.
- 700 1_
- $a Pacovský, Jaroslav $u Charles University in Prague, Faculty of Medicine in Hradec Kralové, Simkova 870, Hradec Kralove, 500 38, Czech Republic. Clinic of Urology, University Hospital Hradec Kralové, Sokolska 581, Hradec Králové, 50005, Czech Republic.
- 700 1_
- $a Košina, Josef $u Charles University in Prague, Faculty of Medicine in Hradec Kralové, Simkova 870, Hradec Kralove, 500 38, Czech Republic. Clinic of Urology, University Hospital Hradec Kralové, Sokolska 581, Hradec Králové, 50005, Czech Republic.
- 700 1_
- $a Žemličková, Helena $u Institute of Clinical Microbiology, University Hospital Hradec Kralové, Sokolska 581, Hradec Králové, 50005, Czech Republic. Charles University in Prague, Faculty of Medicine in Hradec Kralové, Simkova 870, Hradec Kralove, 500 38, Czech Republic.
- 700 1_
- $a Broďák, Miloš $u Charles University in Prague, Faculty of Medicine in Hradec Kralové, Simkova 870, Hradec Kralove, 500 38, Czech Republic. Clinic of Urology, University Hospital Hradec Kralové, Sokolska 581, Hradec Králové, 50005, Czech Republic.
- 773 0_
- $w MED00008208 $t BMC urology $x 1471-2490 $g Roč. 17, č. 1 (2017), s. 33
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28446177 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180404 $b ABA008
- 991 __
- $a 20180418100030 $b ABA008
- 999 __
- $a ok $b bmc $g 1288123 $s 1007450
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 17 $c 1 $d 33 $e 20170426 $i 1471-2490 $m BMC urology $n BMC Urol $x MED00008208
- LZP __
- $a Pubmed-20180404